RecruitingNot ApplicableNCT06701890

Observational Study of Travellers Pathologies

Sponsor

Institut Pasteur

Enrollment

11,000 participants

Start Date

Dec 9, 2024

Study Type

INTERVENTIONAL

Conditions

Travel-Related Illness

Summary

Traveling to emerging countries is associated with a significant risk of encountering health issues specific to the destination, such as gastrointestinal and respiratory infections, malaria episodes, and road traffic accidents.These conditions are associated with behavioral, geographical, or environmental risk factors. A better understanding of these factors will enable the development of targeted recommendations to minimize travel related health issues. The main objective of this study is to determine the incidence of pathologies occurring during travel outside the metropolitan territory.

Eligibility

Min Age: 18 Years

Inclusion Criteria10

For all participants in the EOP study :
Major subject (age ≥ 18)
Owns a smartphone compatible with electronic data collection
Preparing to travel outside mainland France
Affiliated with or covered by Social Security or private insurance
Willing to participate in the EOP study
For the EOP-Arbo Sub-study :
\- Subject who has consented to participate in the EOP_Arbo study.
For the EOP-AMR Sub-study :
Subject who has consented to participate in the EOP_AMR study.

Exclusion Criteria8

For all participants in the EOP study :
Travel duration ≤ 3 days
Travel duration > 12 months
Person traveling as part of an expatriation without planned movement outside the settlement in the destination country
Person under legal protection or unable to express consent for participation
For the EOP-Arbo Sub-study :
\- Individuals deemed clinically and/or biologically unfit by the investigator to undergo the blood samples required for the study.
For the EOP-AMR Sub-study :

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlood sample collection

16 mL at inclusion 16 mL at 1 month after return from travel

OTHERFecal sample collection

1 sample at inclusion 1 sample at day 1, day 7, day 14, day 21, 1 month and 2 month after return from travel

Locations(1)

Medical Center of Institut Pasteur

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06701890